The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Tait D. Shanafelt

Department of Internal Medicine

Mayo Clinic

Rochester

Minnesota

USA

[email]@mayo.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA. 2010 - 2012
  • Mayo Clinic, Rochester, Minnesota. 2012
  • Division of Hematology, Mayo Clinic, Rochester, USA. 2002 - 2010
  • Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. 2007 - 2009
  • Mayo Clinic, Departments of Oncology and Hematology/Oncology, Rochester, Minnesota 55905, USA. 2005

References

  1. Burnout and satisfaction with work-life balance among US physicians relative to the general US population. Shanafelt, T.D., Boone, S., Tan, L., Dyrbye, L.N., Sotile, W., Satele, D., West, C.P., Sloan, J., Oreskovich, M.R. Arch. Intern. Med. (2012) [Pubmed]
  2. Hematologist/oncologist disease-specific expertise and survival: Lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Shanafelt, T.D., Kay, N.E., Rabe, K.G., Inwards, D.J., Zent, C.S., Leis, J.F., Schwager, S.M., Thompson, C.A., Bowen, D.A., Witzig, T.E., Slager, S.L., Call, T.G. Cancer (2012) [Pubmed]
  3. Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia. Shanafelt, T.D., Rabe, K.G., Kay, N.E., Zent, C.S., Call, T.G., Slager, S.L., Bowen, D.A., Schwager, S.M., Nowakowski, G.S. Leuk. Lymphoma (2010) [Pubmed]
  4. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Shanafelt, T.D., Ghia, P., Lanasa, M.C., Landgren, O., Rawstron, A.C. Leukemia (2010) [Pubmed]
  5. Burnout and medical errors among American surgeons. Shanafelt, T.D., Balch, C.M., Bechamps, G., Russell, T., Dyrbye, L., Satele, D., Collicott, P., Novotny, P.J., Sloan, J., Freischlag, J. Ann. Surg. (2010) [Pubmed]
  6. Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia. Shanafelt, T., Zent, C., Byrd, J., Erlichman, C., Laplant, B., Ghosh, A., Call, T., Villalona-Calero, M., Jelinek, D., Bowen, D., Laumann, K., Wu, W., Hanson, C., Kay, N. Leuk. Lymphoma (2010) [Pubmed]
  7. Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia. Shanafelt, T.D., Rabe, K.G., Kay, N.E., Zent, C.S., Jelinek, D.F., Reinalda, M.S., Schwager, S.M., Bowen, D.A., Slager, S.L., Hanson, C.A., Call, T.G. Cancer (2010) [Pubmed]
  8. Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. Shanafelt, T.D., Call, T.G., Zent, C.S., LaPlant, B., Bowen, D.A., Roos, M., Secreto, C.R., Ghosh, A.K., Kabat, B.F., Lee, M.J., Yang, C.S., Jelinek, D.F., Erlichman, C., Kay, N.E. J. Clin. Oncol. (2009) [Pubmed]
  9. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. Shanafelt, T.D., Kay, N.E., Rabe, K.G., Call, T.G., Zent, C.S., Maddocks, K., Jenkins, G., Jelinek, D.F., Morice, W.G., Boysen, J., Schwager, S., Bowen, D., Slager, S.L., Hanson, C.A. J. Clin. Oncol. (2009) [Pubmed]
  10. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Shanafelt, T.D., Kay, N.E., Jenkins, G., Call, T.G., Zent, C.S., Jelinek, D.F., Morice, W.G., Boysen, J., Zakko, L., Schwager, S., Slager, S.L., Hanson, C.A. Blood (2009) [Pubmed]
  11. Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia. Shanafelt, T.D., Byrd, J.C., LaPLant, B., Zent, C.S., Call, T., Secreto, C., Grever, M.R., Lin, T.S., Kay, N.E. Br. J. Haematol. (2009) [Pubmed]
  12. Monoclonal B-cell lymphocytosis: definitions and natural history. Shanafelt, T., Hanson, C.A. Leuk. Lymphoma (2009) [Pubmed]
  13. The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Shanafelt, T.D., Bowen, D.A., Venkat, C., Slager, S.L., Zent, C.S., Kay, N.E., Reinalda, M., Tun, H., Sloan, J.A., Call, T.G. Leuk. Res. (2009) [Pubmed]
  14. Validation of a new prognostic index for patients with chronic lymphocytic leukemia. Shanafelt, T.D., Jenkins, G., Call, T.G., Zent, C.S., Slager, S., Bowen, D.A., Schwager, S., Hanson, C.A., Jelinek, D.F., Kay, N.E. Cancer (2009) [Pubmed]
  15. Predicting clinical outcome in CLL: how and why. Shanafelt, T.D. Hematology. Am. Soc. Hematol. Educ. Program (2009) [Pubmed]
  16. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. Shanafelt, T.D., Geyer, S.M., Bone, N.D., Tschumper, R.C., Witzig, T.E., Nowakowski, G.S., Zent, C.S., Call, T.G., Laplant, B., Dewald, G.W., Jelinek, D.F., Kay, N.E. Br. J. Haematol. (2008) [Pubmed]
  17. A career in surgical oncology: finding meaning, balance, and personal satisfaction. Shanafelt, T. Ann. Surg. Oncol. (2008) [Pubmed]
  18. Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia. Shanafelt, T.D., Lin, T., Geyer, S.M., Zent, C.S., Leung, N., Kabat, B., Bowen, D., Grever, M.R., Byrd, J.C., Kay, N.E. Cancer (2007) [Pubmed]
  19. Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Shanafelt, T.D., Bowen, D., Venkat, C., Slager, S.L., Zent, C.S., Kay, N.E., Reinalda, M., Sloan, J.A., Call, T.G. Br. J. Haematol. (2007) [Pubmed]
  20. T-cell abnormalities in patients with chronic lymphocytic leukemia. Shanafelt, T., Kay, N. Leuk. Lymphoma (2006) [Pubmed]
  21. Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Shanafelt, T.D., Lee, Y.K., Call, T.G., Nowakowski, G.S., Dingli, D., Zent, C.S., Kay, N.E. Leuk. Res. (2006) [Pubmed]
  22. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Shanafelt, T.D., Kay, N.E. Semin. Oncol. (2006) [Pubmed]
  23. Shaping your career to maximize personal satisfaction in the practice of oncology. Shanafelt, T., Chung, H., White, H., Lyckholm, L.J. J. Clin. Oncol. (2006) [Pubmed]
  24. Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine. Shanafelt, T.D., Lee, Y.K., Bone, N.D., Strege, A.K., Narayanan, V.L., Sausville, E.A., Geyer, S.M., Kaufmann, S.H., Kay, N.E. Blood (2005) [Pubmed]
  25. The well-being and personal wellness promotion strategies of medical oncologists in the North Central Cancer Treatment Group. Shanafelt, T.D., Novotny, P., Johnson, M.E., Zhao, X., Steensma, D.P., Lacy, M.Q., Rubin, J., Sloan, J. Oncology (2005) [Pubmed]
  26. Finding meaning, balance, and personal satisfaction in the practice of oncology. Shanafelt, T.D. J. Support. Oncol (2005) [Pubmed]
  27. Relationship between increased personal well-being and enhanced empathy among internal medicine residents. Shanafelt, T.D., West, C., Zhao, X., Novotny, P., Kolars, J., Habermann, T., Sloan, J. J. Gen. Intern. Med (2005) [Pubmed]
  28. Current approach to diagnosis and management of chronic lymphocytic leukemia. Shanafelt, T.D., Call, T.G. Mayo Clin. Proc. (2004) [Pubmed]
  29. Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer?. Shanafelt, T.D., Loprinzi, C., Marks, R., Novotny, P., Sloan, J. J. Clin. Oncol. (2004) [Pubmed]
  30. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Shanafelt, T.D., Madueme, H.L., Wolf, R.C., Tefferi, A. Mayo Clin. Proc. (2003) [Pubmed]
  31. Pathophysiology and treatment of hot flashes. Shanafelt, T.D., Barton, D.L., Adjei, A.A., Loprinzi, C.L. Mayo Clin. Proc. (2002) [Pubmed]
 
WikiGenes - Universities